Nik Cremo

Stock Analyst at Barclays

(1.38)
# 3,640
Out of 5,005 analysts
105
Total ratings
44.7%
Success rate
-0.7%
Average return

Stocks Rated by Nik Cremo

Jack Henry & Associates
Sep 17, 2026
Reiterated: Buy
Price Target: $185
Current: $147.77
Upside: +25.19%
Strategy
Sep 15, 2026
Reiterated: Buy
Price Target: $125 → $160
Current: $157.14
Upside: +1.82%
Chime Financial
Sep 9, 2026
Reiterated: Buy
Price Target: $33 → $40
Current: $26.69
Upside: +49.87%
Affirm Holdings
Aug 28, 2026
Reiterated: Buy
Price Target: $97 → $105
Current: $67.21
Upside: +56.23%
Nayax Ltd.
Aug 26, 2026
Reiterated: Hold
Price Target: ILA 20,727
Current: ILA 13,600
Upside: +52.40%
Bitdeer Technologies Group
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $11.03
Upside: +35.99%
Klarna Group
Aug 18, 2026
Reiterated: Hold
Price Target: $20 → $16
Current: $12.41
Upside: +28.93%
Fiserv
Aug 7, 2026
Reiterated: Hold
Price Target: $58 → $52
Current: $46.02
Upside: +12.99%
Global Payments
Aug 6, 2026
Reiterated: Hold
Price Target: $81 → $89
Current: $84.70
Upside: +5.08%
Block
Aug 6, 2026
Reiterated: Buy
Price Target: $100
Current: $73.31
Upside: +36.41%
Reiterated: Hold
Price Target: $44 → $43
Current: $34.31
Upside: +25.33%
Reiterated: Buy
Price Target: $35 → $39
Current: $30.38
Upside: +28.37%
Reiterated: Buy
Price Target: $640 → $660
Current: $568.26
Upside: +16.14%
Reiterated: Sell
Price Target: $7 → $6
Current: $6.12
Upside: -1.96%
Reiterated: Buy
Price Target: $420
Current: $367.74
Upside: +14.21%
Reiterated: Hold
Price Target: $55 → $57
Current: $54.28
Upside: +5.01%
Reiterated: Hold
Price Target: $172 → $165
Current: $177.06
Upside: -6.81%
Reiterated: Hold
Price Target: $340 → $315
Current: $396.23
Upside: -20.50%
Reiterated: Buy
Price Target: $34 → $39
Current: $18.62
Upside: n/a
Reiterated: Hold
Price Target: $14 → $27
Current: $17.00
Upside: n/a
Reiterated: Buy
Price Target: $32 → $30
Current: $2.99
Upside: n/a
Reiterated: Buy
Price Target: $160 → $130
Current: $41.60
Upside: n/a
Reiterated: Buy
Price Target: $24
Current: $3.75
Upside: n/a